Artificial Pancreas Device Systems Market Report and Forecast 2025-2034

The global artificial pancreas device systems market was valued at USD 653.81 Million in 2024, driven by increasing prevalence of diabetes across the globe. The market is expected to grow at a CAGR of 20.00% during the forecast period of 2025-2034, with the values likely to reach USD 4.04 billion by 2034.

Global Artificial Pancreas Device Systems Market Overview

Artificial pancreas also referred as closed-loop system, an automated insulin delivery system, or an autonomous system mimics the blood glucose regulation of a healthy pancreas. Mostly, an artificial pancreas consists of three parts, namely, continuous glucose monitor (CGM), automatic insulin delivery system, and controller/control algorithm which regulates the administration of insulin in response to current blood glucose measurements. The device is vital for the patients mainly with type 1 diabetes as they lack the tendency to produce the insulin to regulate blood glucose level. However, the device is also useful for patients with type 2 diabetes who inject insulin occasionally.

As per the latest data from the International Diabetes Federation 2022, nearly 537 million adults (aged 20-79 years) are living with diabetes, which indicates that every 1 in 10 person is found to affected with diabetes. As per the same source, it is predicted that nearly 643 million people will be affected with the disease by 2030 and 783 million by 2045. Moreover, the market is also driven by the unhealthy lifestyle and obesity that can result into diabetes at later stages.

Global Artificial Pancreas Device Systems Market Growth Drivers

Increasing Diabetes Prevalence to Propel the Market Value Significantly

According to the International Diabetes Federation 2022, about 1.52 million people under the age of 20 are living with the type 1 diabetes globally. The World health Organization (WHO) estimates shows that diabetes is directly responsible for 1.5 million fatalities worldwide each year. In order to manage the condition effectively, it is crucial to constantly balance giving appropriate amount of insulin along with monitoring blood glucose levels. As a result, the usage of artificial pancreas is on the rise, envisioned to mitigate the comorbidities associated with the chronic condition.

Growing Obesity Rates are Projected to Boost Artificial Pancreas Device Systems Market Demand

According to the World Health Organization (WHO), around 2.5 billion adults (18 years or older) were overweight, out of which around 890 million adults were living with obesity in 2022. This equates to about 43% of the adults being overweight, which shows an increase from 1990 when 25% of adults aged 18 years and above were overweight. A study conducted on 128,571 individuals from the United States, during 2016 to 2021 indicated that 34% of adults with type 1 diabetes were overweight, while 28% had obesity. Clearly, obesity is the main risk factor for diabetes and can contribute to nearly half of the patient with diabetes.

Global Artificial Pancreas Device Systems Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Technological Advancements

For a diabetic patient, it is necessary to maintain the dose titration and timely injection in order to maintain the optimal glycemic control. However, in recent years technological advancements have led to the integration of CGM and insulin pumps in one device. This has created paradigm shifts in the management of diabetes patient with the development of artificial pancreas.

Increased Research and Initiatives by Institutions

Continuous research and collaboration by organizations has revolutionized the management of diabetes with artificial pancreas. For instance, FDA is contributing to the development of an artificial pancreas device system by prioritizing the review of research protocol studies defining performance and safety standards. It is also working on guiding the industry with clear guidelines, encouraging collaboration between public and private researchers, co-sponsoring public forums, and figuring out ways to reduce study and review times.

Clinical Evidence

Adoption of artificial pancreas device system is being fueled by mounting clinical evidence for its safety and efficacy. Studies have shown that artificial pancreas device system users have significant improvements in glycemic control, decrease in the frequency of hypoglycemia, and an improvement in their quality of life.

Integration with Mobile Devices and Apps

Manufacturers are trying to integrate artificial pancreas in mobiles or applications that can allow the patients to quickly check their glucose levels, receive alerts and notification. Such facilities may prove to be beneficial for patients while providing better experience.

Global Artificial Pancreas Device Systems Market Segmentation

The report titled “Artificial Pancreas Device Systems Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Device Type

• Threshold Suspend Device Systems
• Control-to-Range (CTR) Systems
• Control-to-Target (CTT) Systems

Market Breakup by End User

• Hospitals
• Clinics
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Artificial Pancreas Device Systems Market Share

Market Segmentation Based on Device Type is Anticipated to Witness Substantial Growth

Based on device type, the market segmentation includes threshold suspend device systems, control-to-range (CTR) Systems, and control-to-target (CTT) systems. Threshold suspend device system can automatically suspend the insulin delivery if the blood glucose level gets low. Moreover, the control-to-range (CTR) seek to keep blood glucose levels within a specified target range in response to the CGM. While the control-to-target (CTT) systems provide the specific glucose levels that are set by healthcare providers. The type of device used may differ, based on the diverse needs of individuals with diabetes.

Global Artificial Pancreas Device Systems Market Analysis by Region

Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America and Europe are likely to hold a significant market share, which can be attributed a well-established infrastructure that can technological advancements along with increasing incidence of diabetic patients. Growing collaborations between academic institutions and MedTech companies is also poised to boost research initiatives and fuel the region's market growth.

Asia Pacific is projected to witness substantial growth. It can be accredited to increasing number of diabetic patients due to changing lifestyles and increasing initiatives by the government.

Leading Players in the Global Artificial Pancreas Device Systems Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medtronic
• EOFLOW CO., LTD
• Beta Bionics
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Dexcom
• Medtrum Technologies Inc.
• Nikkiso Co., Ltd.
• Pancreum, Inc.
• Abbott
• Admetsys Corporation
• INREDA® DIABETIC B.V.
• Diabeloop SA

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in the Global Artificial Pancreas Device Systems Market Report

• What was the global artificial pancreas device systems market value in 2024?
• What is the global artificial pancreas device systems market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is market segmentation based on product type?
• Who are the major end users in the market?
• What are the major factors aiding the global artificial pancreas device systems market demand?
• How has the artificial pancreas device systems market performed so far and how is it anticipated to perform in the coming years?
• What are the major market trends influencing the market?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How does the prevalence of diabetes affect the market landscape?
• How does the rise in the obesity impact the market size?
• Which device type will dominate the market share?
• How does the rise in the geriatric population impact the market size?
• Which region is expected to have a high market value in the coming years?
• Which end-user will experience the highest demand in the market segment?
• Who are the key players involved in the artificial pancreas device systems market?
• What is patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.